Jörg Weyermann
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
- Co-authors
- Andreas ZimmerDirk LochmannChristian HaassIsabel ScherpingAnne EckertLaurent PradierJoanna B. StrosznajderF. Müller‐Spahn
- Journals
- European Journal of Pharmaceutics and Biopharmaceutics (3 papers)Journal of Controlled Release (3 papers)International Journal of Pharmaceutics (2 papers)Current Pharmaceutical Biotechnology (1 paper)Journal of Microencapsulation (1 paper)
- Partner nations
- AustriaGermanyNetherlands
In The Last Decade
Jörg Weyermann
12 papers receiving 959 citations
Peers
Comparison fields: 5 of 112
- Pharmaceutical Science 63
- Biomaterials 112
- Biological Psychiatry 21
- Physiology 214
- Molecular Biology 501
Countries citing papers authored by Jörg Weyermann
This map shows the geographic impact of Jörg Weyermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörg Weyermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörg Weyermann more than expected).
Fields of papers citing papers by Jörg Weyermann
This network shows the impact of papers produced by Jörg Weyermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörg Weyermann. The network helps show where Jörg Weyermann may publish in the future.
Co-authors
The 25 scholars most cited alongside Jörg Weyermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 36 | |
| 2 | 2005 | 37 | |
| 3 | 2005 | 47 | |
| 4 | 2005 | 33 | |
| 5 | 2005 | 26 | |
| 6 | 2004 | 63 | |
| 7 | 2004 | 407 | |
| 8 | 2004 | 21 | |
| 9 | 2004 | 249 | |
| 10 | 2004 | 25 | |
| 11 | 2004 | 15 | |
| 12 | 2004 | 40 |
About Jörg Weyermann
Jörg Weyermann is a scholar working on Bioengineering, Biophysics, Molecular Biology, Small Animals and Physiology, having authored 12 papers that have together received 999 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (7 papers), Protein Interaction Studies and Fluorescence Analysis (4 papers), DNA and Nucleic Acid Chemistry (4 papers), Advanced biosensing and bioanalysis techniques (3 papers), Protein purification and stability (2 papers), Bacteriophages and microbial interactions (1 paper), Analytical Chemistry and Chromatography (1 paper) and bioluminescence and chemiluminescence research (1 paper). The work is most often cited by research in Pharmaceutical Science (63 citations), Biomaterials (112 citations), Biological Psychiatry (21 citations), Physiology (214 citations) and Molecular Biology (501 citations). Jörg Weyermann has collaborated with scholars based in Austria, Germany and Netherlands. Frequent co-authors include Andreas Zimmer, Dirk Lochmann, Christian Haass, Isabel Scherping, Anne Eckert, Laurent Pradier, Joanna B. Strosznajder, F. Müller‐Spahn, Christian Czech and Astrid Bonert. Their work appears in journals such as European Journal of Pharmaceutics and Biopharmaceutics, Journal of Controlled Release, International Journal of Pharmaceutics, Current Pharmaceutical Biotechnology and Journal of Microencapsulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.